HomeAQS • CVE
add
Aequus Pharmaceuticals Inc
Previous close
$0.015
Year range
$0.010 - $0.050
Market cap
1.97M CAD
Avg Volume
98.60K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 161.41K | 64.02% |
Operating expense | 736.56K | 2.30% |
Net income | -683.03K | 2.55% |
Net profit margin | -423.16 | 40.58% |
Earnings per share | — | — |
EBITDA | -660.25K | 0.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 44.08K | 45.05% |
Total assets | 1.01M | 14.05% |
Total liabilities | 6.62M | 80.01% |
Total equity | -5.61M | — |
Shares outstanding | 132.63M | — |
Price to book | -0.38 | — |
Return on assets | -157.42% | — |
Return on capital | -253.30% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -683.03K | 2.55% |
Cash from operations | -706.10K | -48.61% |
Cash from investing | — | — |
Cash from financing | 508.14K | 10.14% |
Net change in cash | -197.96K | -1,335.35% |
Free cash flow | -489.41K | -113.89% |
About
Founded
2013
Headquarters
Website
Employees
12
